Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2005
08/11/2005US20050176825 a mixture of quinic acid and salts, and nontoxic inert carriers or diluents; solvent extraction
08/11/2005US20050176824 Novel substance having antitumor/anti-inflammatory activity
08/11/2005US20050176823 Intra-operative procedure for post-operative pain control
08/11/2005US20050176821 Meta-substituted phenylene sulphonamide derivatives
08/11/2005US20050176820 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
08/11/2005US20050176819 parasiticides, in particularly against Plasmodium and babesia; antimalarial agents
08/11/2005US20050176817 Anticancer agents; prevention of infections; autoimmune diseases;antiarthritic agents; cystic fibrosis
08/11/2005US20050176816 Controlling infections; antiallergens; antiarthritic agents; cardiovascular disorders
08/11/2005US20050176815 Malaria therapy
08/11/2005US20050176814 mono- or polydeuterated 4-(p-Methylsulfonylphenyl]-3-phenyl-2-(5H)-furanones; degenerative joint disorders, acute pain and primary dysmenorrhea
08/11/2005US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde
08/11/2005US20050176812 dosing regimen comprising administering discodermolide to humans once followed by a 3-week time period before administering the next dose; maintaining a balance efficiency and toxicity; antitumor agents
08/11/2005US20050176811 Vitamin combination for providing protection during the chemotherapy and/or radio-therapy of malignant tumours
08/11/2005US20050176809 Method and compositions for treatment of painful disorders
08/11/2005US20050176808 Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
08/11/2005US20050176807 Composition and method for use in cartilage affecting conditions
08/11/2005US20050176806 Use of 1-[3-hydroxy-1-adamantylamino]acetyl-2-cyano-pyrrolidine, for example with other anticholesterol drugs such as statins
08/11/2005US20050176804 Method and material for free radical scavenging in human tissue
08/11/2005US20050176803 Indole derivatives as anti-inflammatory agents
08/11/2005US20050176802 Pyrrole substituted 2-indolinone protein kinase inhibitors
08/11/2005US20050176801 Acyl bicyclic derivatives of pyrrol
08/11/2005US20050176800 Preterm labor, dysmenorrhea, asthma, hypertension, fertility disorder, sexual dysfunction, undesired blood clotting, bone disorders, preeclampsia or eclampsia, or an eosinophil disorder; use with phosphodiesterase inhibitors; e.g. 7-[(2R,3R)-3-Chloro-1-(4-hydroxynonyl)-pyrrolidin-2-yl]-hept-5-enoic acid
08/11/2005US20050176799 drugs such as 1-Benzyl-3-(2-furyl)-5-trifluoromethylpyrazole, capable of modulating biosynthesis of cyclic guanosine monophosphate, used for therapy and prophylaxis of cardiovascular disorders such as hypertension, angina pectoris, cardiac insufficiency, thrombosis or atherosclerosis
08/11/2005US20050176798 Containing microcrystalline cellulose, lubricant, colloidal silica and lactose; use in treating depression, Parkinson's disease and severe psychotic disorders, such as schizophrenia and schizoaffective disorders.
08/11/2005US20050176796 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/11/2005US20050176795 For therapy and prophylaxis of obesity and diabetes
08/11/2005US20050176793 formed by dissolving Irbesartan in a mixture of haloalkane and alcohol solvents, then distilling off the solvent from the solution and drying; non-peptide angiotensin antagonist, used for treatment of cardiovascular disorders such as hypertension and heart failure
08/11/2005US20050176792 2-arylcarbonylamino-4,5,6 or 7-(keto(alkyl))-benzimidazoles; cancer, inflammation, immunological disorders and allergic disorders
08/11/2005US20050176791 5-HT2B receptor antagonists
08/11/2005US20050176789 Modulators of ATP-Binding Cassette transporters
08/11/2005US20050176788 Such as 2-[N-(4,5-dimethoxy-2-hydroxybenzoyl)amino]-4-[(2-diisopropylaminoethyl)aminocarbonyl]-1,3-thiazole; compounds relax gastric fundus, to relieve feeling of early satiety and bloating; gastrointestinal motility disorders
08/11/2005US20050176787 Thiazolidinediones alone or in combination with other therapeutic agents for inhibiting or reducing tumour growth
08/11/2005US20050176786 Anticancer agents; inhibit Abelson tyrosine kinase, Ron receptor tyrosine kinase, Met receptor tyrosine kinase, Fms-like tyrosine kinase-3, or p21-activated kinase-4; e.g. 3-substituted-5-(carbonylamino or sulfonamido)-1H-pyrazolo[3,4-d]thiazole
08/11/2005US20050176782 Medicament and method for treating vulodynia
08/11/2005US20050176781 Process for the preparation of [S(-) amlodipine - L (+)- hemitartarate
08/11/2005US20050176780 2,5-disubstituted 3-mercaptopentanoic acid
08/11/2005US20050176777 administering anabasine, anatabine, nornicotine and carriers, diluents or vehicles, for treatment drug abuse and dependence
08/11/2005US20050176776 Mitotic kinesin inhibitors
08/11/2005US20050176775 Substituted pyridinones
08/11/2005US20050176774 determining isomeric ratios omeprazole mixtures
08/11/2005US20050176773 Antimetastasis agents e.g. 6-[4-Amino-5-(2,6-difluoro-benzoyl)-thiazol-2-ylamino]-N-2-dimethylamino-2-methyl-propyl)-nicotinamide; protein kinase inhibitor
08/11/2005US20050176772 Melanocortin MCR4 agonists; treating female sexual dysfunction, male erectile dysfunction, obesity or diabetes; e.g. [1-tert-Butyl-4-(2,4-difluoro-phenyl)-pyrrolidin-3-yl]-(4-hydroxy-3,5-dimethyl-4-phenyl-piperidin-1-yl)-methanone or its hydrochloride
08/11/2005US20050176770 Novel 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
08/11/2005US20050176769 Novel inhibitors of chymase
08/11/2005US20050176767 Pyridine carboxamide and methods for inhibiting HIV integrase
08/11/2005US20050176766 2,3-Oxidosqualene-lanosterol cyclase inhibitors
08/11/2005US20050176765 For therapy of glaucoma, dementia such as Alzheimer's disease and vascular dementia, depression, attention deficit disorder, sleep disorder, schizophrenia, pain, ischemia; -[1-[1-(3-Thienoyl)piperidin-4-yl]piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one
08/11/2005US20050176764 Medicine for treating cancer
08/11/2005US20050176763 Administering a therapeutically effective amount of 3-thia-4-(2-oxy/hydroxyphenyl)quinolin-2-one derivative to a patient to treat erectile dysfunction or irritable bowel syndrome
08/11/2005US20050176762 Tachykinin receptor subtypes NK3 and NK2 (NK neurokinin); various diseases including respiratory system disorders, autoimmune disorders, psychological disorders, skin disorders
08/11/2005US20050176761 Tetrahydroisoquinoline derivatives for treating protein trafficking diseases
08/11/2005US20050176760 and tumors; imino-, thiocarbonyl- or hydroxyimino-substituted N-heterocyclic amide compounds such as 2-(3-aminomethylphenylamino)-N-[3-chloro-4-(2-hydroxyiminopyrrolidin-1-yl)phenyl]-2-phenylacetamide
08/11/2005US20050176759 7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment cns disorders
08/11/2005US20050176758 2-(hydroxy or methoxymethoxy)-4-(carboxy or alkoxycarbonyl)-5-(fluoro or hydrogen)-7-oxabicyclo(4.1.0)hept-3-ene chemical intermediates to neuraminidase inhibitors
08/11/2005US20050176757 For example, 6-[4-(4-Amino-5-chloro-2-methoxy-benzoylamino)-3-methoxy-piperidin-1-yl]-hexanoic acid 1-aza-bicyclo[2.2.2]oct-3-yl ester; for treatment of gastrointestinal disorders including gastroparesis, gastroesophageal reflux
08/11/2005US20050176756 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted
08/11/2005US20050176754 Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
08/11/2005US20050176753 controlling signal transduction; anticancer agents; antitumor agnets; atherosclerosis; vision defects; antidiabetic agents; antiinflammatory agents
08/11/2005US20050176752 Such as 2,2,4-trimethyl-1,3-dioxolo[4,5-c]piperidin-7-ol; reacting methanesulfonic acid 6-hydroxy-2,2,6-trimethyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-ylmethyl ester with phthalimide; avoids the use of reagents such as corrosive triflic anhydride and toxic sodium azide; intermediates to antivirals
08/11/2005US20050176751 Selective H1 histamine receptor antagonists; bronchial asthma, allergic rhinitis, conjunctivitis, dermatitis, urticaria and other allergic diseases; e.g. 3-(4-[1-(2-methoxyethyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]piperidin-1-ylmethyl)benzoic acid
08/11/2005US20050176750 Treating proliferative disorders such as cancer, autoimmune or inflammatory diseases such as psoriasis; e.g. 4-(3-Bromo-4,5-dimethoxyphenyl)-3-cyano-7-dimethylamino-4H-chromene; use with known anticancer drugs or radiotherapy
08/11/2005US20050176749 Modulators of glucocorticoid receptor, AP-1, and/or NF-kB activity and use thereof
08/11/2005US20050176748 Vinorelbine derivatives
08/11/2005US20050176747 hypertension and asthma; vasorelaxants
08/11/2005US20050176746 Treating eating disorders and digestive disorders wth loperamide
08/11/2005US20050176745 Based on spiro(1-azabicyclo[2.2.2]octane-3,2'(3'H)-furo[2,3-b]pyridine) ring; ligands for nicotinic acetylcholine receptors; Alzheimer's disease, cognitive or attention disorders, anxiety, depression, smoking cessation, neuroprotection, schizophrenia, analgesia, Tourette's and Parkinson's
08/11/2005US20050176744 nitrogen heterocyclyl-(thio)carbonyl- quinoline derivatives used for treating cervical carcinoma or ovarian adenocarcinoma
08/11/2005US20050176743 Sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents
08/11/2005US20050176742 Novel compounds and their use in therapy
08/11/2005US20050176741 Quinazoline derivative and medicine
08/11/2005US20050176740 Synergistic for cancer characterized by ras oncogene overexpression; N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine
08/11/2005US20050176739 Xanthine derivatives; adenosine receptor antagonists; anorexia; 8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine
08/11/2005US20050176737 Mitotic kinesin inhibitors
08/11/2005US20050176732 Enantiomers of 1-(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine
08/11/2005US20050176731 N-[5-({(2S)-3-[(4-{4-[(4-benzylpiperidin-1-yl)carbonyl]phenyl}cyclohexyl)amino]-2-hydroxypropyl}oxy)-2-hydroxyphenyl]methanesulfonamide; beta 3 receptors agonist; gastrointestinal diseases; antiobesity, antidiabetic, cicatrizing agents, tocolytics, dysmenorrhea, antiglaucomatous; amidation
08/11/2005US20050176729 Indole derivatives useful for the treatment of CNS disorders
08/11/2005US20050176728 Agonist or antgonist and binders and inversion of agonist; use in the treatment of metabolic, immune, infection-related and melanocortin receptor mediated disorders
08/11/2005US20050176727 Male erectile dysfunction; 1-(3-chlorophenyl)-3-(4-pyridin-2-yl-piperazin-1-yl)propan-1-one O-methyloxime
08/11/2005US20050176725 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide; antitumor; antiproliferative agent; synergistic therapy for resistant; Bcr/Abl, leukemia
08/11/2005US20050176724 2-Methyl-5-(2-{4-[3-(1-methylpiperidin-4-yl)benzyl]piperidin-1-yl}ethoxy)quinoline hydrochloride; antagonist of 5-serotonin (HT)1 type receptors;antidepressant and anxiolytic agent
08/11/2005US20050176723 (Halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
08/11/2005US20050176722 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
08/11/2005US20050176721 2,5-Diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylprimidines
08/11/2005US20050176720 Pharmaceutical composition for the treatment of CNS and other disorders
08/11/2005US20050176718 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors
08/11/2005US20050176717 N-(3-Amino-propyl)-N-[(3-benzyl-quinoxalin-2-yl)-cyclopropyl-methyl]-4-methylbenzamide; antiproliferative, antitumor agent, viricide; inhibitor of Eg5 protein, associated with proliferating cells in metaphase stage of mitosis; mitotic arrest and apoptosis; small molecules
08/11/2005US20050176716 (2,3-5,6 aryl-heteroaryl)-bicyclo(2,2,2,)octane-amide derivatives; antiinflammatory, obesity, antidiabetic agent, autoimmune disease, asthma, arthritis; non-steroidal; side effect reduction; pharmacokinetics
08/11/2005US20050176715 Piperidine derivatives
08/11/2005US20050176714 Pyridazine derivatives
08/11/2005US20050176713 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
08/11/2005US20050176712 Integrin expression inhibitor
08/11/2005US20050176711 Phthalazine derivatives for treating inflammatory diseases
08/11/2005US20050176710 Aryl-substituted heterocycles, process for their preparation and their use as medicaments
08/11/2005US20050176709 Selective NPY (Y5) antagonists
08/11/2005US20050176708 Piperidine derivatives useful as modulators of chemokine receptor activity
08/11/2005US20050176707 Compositions and methods for inducing cell dedifferentiation
08/11/2005US20050176706 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
08/11/2005US20050176705 5-Chloro-1-(3,5-dichloro-2-methoxy benzenesulfonyl)-4-piperazin-1-yl-1H-indole trifluoroacetic acid salt; 5-hydroxytryptamine (serotonin) HT6 receptor antagonists; antidepressant, anxiolytic agent, cognition activator; ADHD, Alzheimer's and Parkinson's disease, drug and nicotine abuse
08/11/2005US20050176704 Hydroxymorpholinone derivative and medicinal use thereof
08/11/2005US20050176703 Heterocyclic antiviral compounds
1 ... 4582 4583 4584 4585 4586 4587 4588 4589 4590 4591 4592 4593 4594 4595 4596 4597 4598 4599 4600 4601 4602 ... 7860